CAROLYN FRY: Open Payments
NPI 1700403276 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 82 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $664 · 2025 $1,763
Food & beverage: $1,488Education: $275
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $241 |
| AstraZeneca Pharmaceuticals LP | 7 | $192 |
| Janssen Biotech, Inc. | 4 | $159 |
| ABBVIE INC. | 4 | $150 |
| PFIZER INC. | 7 | $105 |
| Tempus AI, Inc | 3 | $86 |
| Gilead Sciences, Inc. | 1 | $75 |
| Daiichi Sankyo Inc. | 3 | $73 |
| ARRAY BIOPHARMA INC | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
Products named: KISQALI, VENCLEXTA, Enhertu, RYBREVANT, XT CDX, Trodelvy, Nubeqa, TECVAYLI.
Industry payments across TX — which companies pay providers there.
